LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$16.71
52W Range
$15.34 - $20.25
50D Avg
$16.65
200D Avg
$16.65
Market Cap
$317.18M
Avg Vol (3M)
$1.25M
Beta
-
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.